ArticleInorganica chimica acta2012
Preparation of aluminum(III) (bis(amido)pyridine)(thiolate) complexes: unexpected transmetalation mediated by LiAlH(4).
Article in Inorganica chimica acta, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sulfide Oxidation by OPolyhedron · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Treatment of an unsymmetrical bis(imino)pyridyl-thiolate zinc(II) complex [Zn(II)(LN(3)S)(OTf)] (1) with LiAlH(4) results in the double reduction of the two imino groups in the ligand backbone, and at the same time causes a rare transmetalation reaction to occur. The products formed in this reaction are two novel aluminium(III) bis(amido)pyridyl-thiolate complexes [(R,S/S,R-[Al(III)(LH(2)N(3)S)(THF)] (2a) and [(R,R/S,S-[Al(III)(LH(2)N(3)S)(THF)] (2b), which are diastereomers of each other. These complexes have been characterized by single-crystal X-ray diffraction and (1)H NMR spectroscopy. Single crystal X-ray structure analysis shows that the Al(III) ion is bound in an almost idealized square pyramidal geometry in 2a, while being held in a more distorted square pyramidal geometry in 2b. The major difference between 2a and 2b arises in the orientation of the terminal methyl groups of the ligand backbone in relation to the Al(III)N(3)S plane. These two complexes are crystallized at different temperatures (room temperature vs -35 °C), allowing for their separate isolation. Structural analysis shows that these complexes are reduced by the formal addition of one hydride ion to each imino group, resulting in a deprotonated bis(amido)pyridyl-thiolate ligand. A detailed analysis of metrical parameters rules out the possibility of pure one- or two-electron reduction of the π-conjugated bis(imino)pyridine framework. (1)H NMR spectra reveal a rich pattern in solution indicating that the solution state structures for 2a and 2b match those observed in the solid-state crystal structures, and reveal that both complexes are severely conformationally restricted. Direct organic synthetic methods failed to produce the reduced bis(amino)pyridyl-thiol ligand in pure form, but during the course of these efforts an unusual unsymmetrical aminopyridyl ketone, 1-(6-(1-(2,6-diisopropylphenylamino)ethyl)pyridin-2-yl)ethanone was synthesized in good yield and can be used as a possible precursor for further ligand development.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.